PRELUDE THERAPEUTICS INC

PRLDNASDAQ

🏆 #3457 by market capEarnings Nov 10US Equity

$4.14▲ $0.26 (+6.70%)

Pre-market · at close

24h▲ 6.7%

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

$240M

Small Cap

📈Revenue Growth (YoY)

73.4%

High Growth

📊Gross Margin

98.3%

High

💵FCF Margin

-148.3%

Thin

⚖️P/S Ratio

10.7x

Elevated

Otter Score

—

Insufficient data

🔭

No analyst ratings for PRLD

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.